These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6490618)

  • 1. Extension and structural variability of the antithrombin-binding sequence in heparin.
    Lindahl U; Thunberg L; Bäckström G; Riesenfeld J; Nordling K; Björk I
    J Biol Chem; 1984 Oct; 259(20):12368-76. PubMed ID: 6490618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of the antithrombin-binding sequence in heparin.
    Thunberg L; Bäckström G; Lindahl U
    Carbohydr Res; 1982 Mar; 100():393-410. PubMed ID: 7083257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.
    Lindahl U; Bäckström G; Thunberg L
    J Biol Chem; 1983 Aug; 258(16):9826-30. PubMed ID: 6885772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.
    Kusche M; Bäckström G; Riesenfeld J; Petitou M; Choay J; Lindahl U
    J Biol Chem; 1988 Oct; 263(30):15474-84. PubMed ID: 3139669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
    Lindahl U; Bäckström G; Thunberg L; Leder IG
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6551-5. PubMed ID: 6935668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
    Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
    Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of the antithrombin-binding sequence in the heparin chain.
    Oscarsson LG; Pejler G; Lindahl U
    J Biol Chem; 1989 Jan; 264(1):296-304. PubMed ID: 2909522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of monosaccharide residues in heparin binding to antithrombin III.
    Atha DH; Lormeau JC; Petitou M; Rosenberg RD; Choay J
    Biochemistry; 1985 Nov; 24(23):6723-9. PubMed ID: 4084555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variation in heparin octasaccharides with high affinity for antithrombin III.
    Atha DH; Stephens AW; Rimon A; Rosenberg RD
    Biochemistry; 1984 Nov; 23(24):5801-12. PubMed ID: 6525337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments.
    Horne A; Gettins P
    Biochemistry; 1992 Mar; 31(8):2286-94. PubMed ID: 1311598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A major common trisulfated hexasaccharide core sequence, hexuronic acid(2-sulfate)-glucosamine(N-sulfate)-iduronic acid-N-acetylglucosamine-glucuronic acid-glucosamine(N-sulfate), isolated from the low sulfated irregular region of porcine intestinal heparin.
    Yamada S; Yamane Y; Tsuda H; Yoshida K; Sugahara K
    J Biol Chem; 1998 Jan; 273(4):1863-71. PubMed ID: 9442018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of critical groups required for the binding of heparin to antithrombin.
    Atha DH; Stephens AW; Rosenberg RD
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1030-4. PubMed ID: 6583694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
    Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
    J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular dichroism spectroscopy of heparin-antithrombin interactions.
    Stone AL; Beeler D; Oosta G; Rosenberg RD
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7190-4. PubMed ID: 6961402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.
    Petitou M; Casu B; Lindahl U
    Biochimie; 2003; 85(1-2):83-9. PubMed ID: 12765778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
    Razi N; Lindahl U
    J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin-binding oligosaccharides: structural diversities in a unique function?
    Guerrini M; Mourier PA; Torri G; Viskov C
    Glycoconj J; 2014 Oct; 31(6-7):409-16. PubMed ID: 25145542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant activity of heparin octasaccharide.
    Ototani N; Yosizawa Z
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites.
    Kusche M; Torri G; Casu B; Lindahl U
    J Biol Chem; 1990 May; 265(13):7292-300. PubMed ID: 2332430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
    Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
    J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.